Table 1.
Characteristics of patients.
| Age (Years) Mean (SD) | 64.6 (12.24), Range 18–97 Years | |
| Gender (M/F) | 2202 (54.8%)/1814 (45.2%) | |
| Karnofsky mean (SD) | 61.8 (18.73), range 10–100 | |
| Primary tumor | Lung | 1089 (27.1%) |
| Gastrointestinal | 647 (16.1%) | |
| Breast | 480 (11.9%) | |
| Pancreas | 349 (8.7%) | |
| Urological | 242 (6.0%) | |
| Prostate | 224 (5.6%) | |
| Head-neck | 205 (5.1%) | |
| Gynecologic | 185 (4.6%) | |
| Liver | 135 (3.4%) | |
| Haematological | 98 (2.4%) | |
| Others | 511 (12.7%) | |
| Disease | Loco-regional | 642 (16.0%) |
| Metastatic | 3374 (84.0%) | |
| Anticancer treatment | Disease-oriented | 3030 (78.0%) |
| Palliative Care | 854 (22.0%) | |
| Place of Visit | Outpatients | 1378 (34.3%) |
| Day hospital | 462 (11.5%) | |
| Home care | 577 (14.4%) | |
| Hospice | 101 (2.5%) | |
| Hospital inpatient | 1498 (37.3%) | |
| Setting | Palliative care | 720 (17.9%) |
| Oncology | 2087 (52.0%) | |
| Pain therapy | 1184 (29.5%) | |
| Radiotherapy | 25 (0.6%) | |
| Mean background pain intensity at T0 | 3.0 (SD 1.83) | |
| Mean opioid doses (expressed as oral morphine equivalents) | 69.4 mg/day (SD 88.7) mg/day |